Rosetta Genomics Ltd.
ROSG
ROSG was delisted on the 21st of May, 2018.
10 hedge funds and large institutions have $1.01M invested in Rosetta Genomics Ltd. in 2016 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 1 reducing their positions, and 3 closing their positions.
400% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 1
9% less funds holding
Funds holding: 11 → 10 (-1)
26% less capital invested
Capital invested by funds: $1.36M → $1.01M (-$350K)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$147K |
| 2 |
HCM
Highlander Capital Management
Short Hills,
New Jersey
|
+$46.5K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
+$41.1K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$27.6K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$15.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$338K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$196K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$5K |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$956 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HCM
1
Highlander Capital Management
Short Hills,
New Jersey
| $570K | +$46.5K | +3,646 | +9% |
|
|
2
Morgan Stanley
New York
| $263K | +$147K | +11,550 | +135% |
|
|
VKH
3
Virtu KCG Holdings
New York
| $66K | +$41.1K | +3,226 | +181% |
|
4
California Public Employees Retirement System
Sacramento,
California
| $55K | – | – | – |
|
|
5
Citadel Advisors
Miami,
Florida
| $28K | +$27.6K | +2,161 | New |
|
|
6
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $16K | +$15.5K | +1,213 | New |
|
|
ICAS
7
Investors Capital Advisory Services
Lynnfield,
Massachusetts
| $12K | +$842 | +66 | +7% |
|
|
8
UBS Group
Zurich,
Switzerland
| $1K | -$5K | -392 | -89% |
|
9
Wells Fargo
San Francisco,
California
| $1K | – | – | – |
|
10
Citigroup
New York
| $1K | +$242 | +19 | +22% |
|
|
AFM
11
Anson Funds Management
Dallas,
Texas
| – | -$338K | -22,879 | Closed |
|
|
SM
12
Sabby Management
Miami Beach,
Florida
| – | -$196K | -13,246 | Closed |
|
|
13
Group One Trading
Chicago,
Illinois
| – | -$956 | -75 | Closed |
|
ROSG Hedge Fund Activity: Q1 2016 in Review
10 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Rosetta Genomics Ltd. (ROSG) for Q1 2016, worth a combined $1.01M — down 26% from $1.36M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of ROSG and 2 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 5 added.
The largest buyer was Morgan Stanley, adding an estimated $147K. The largest seller was Anson Funds Management, exiting entirely with an estimated $338K sold.
- 10 institutional investors held Rosetta Genomics Ltd. (ROSG) as of Q1 2016, down from 11 in Q4 2015.
- Funds reported $1.01M of Rosetta Genomics Ltd. stock for Q1 2016, down 26% quarter-over-quarter.
- 2 funds opened new Rosetta Genomics Ltd. positions in Q1 2016 and 3 closed out, a net change of -1 holder.
- The largest Rosetta Genomics Ltd. buyer in Q1 2016 was Morgan Stanley, an estimated $147K added.
- The largest Rosetta Genomics Ltd. seller in Q1 2016 was Anson Funds Management, an estimated $338K sold.
Based on aggregated 13F filings for Q1 2016.